Healthcare Trust of America, Inc. (NYSE: HTA) announced today that it had executed a new $300 million senior unsecured, 4-year term loan (the "New Term Loan"). The New Term Loan replaces the existing $300 million term loan (the "Existing Term Loan") that was originally scheduled to mature in March 2016. The New Term Loan will have an initial maturity date of January 2018 and can be extended by HTA for up to 1 year, subject to certain conditions.
Based on HTA's recent upgrade by Moody's to Baa2 (announced on December 19, 2013), the New Term Loan will be initially priced at LIBOR plus 120 bps. This represents a reduction of 65 bps from the borrowing cost on the Existing Term Loan as of December 18, 2013. The ratings upgrade also reduced the borrowing rate and facility fees on HTA's existing (i) $650 million revolving credit facility maturing in 2016 and (ii) $155 million term loan maturing in 2019. As a result, total interest expense savings on the current outstanding balances on these facilities are anticipated to total over $2.5 million in 2014.
J.P. Morgan Securities LLC and Wells Fargo Securities, LLC served as Joint Bookrunners and Joint Lead Arrangers with JP Morgan Chase Bank, N.A. serving as the Administrative Agent and Wells Fargo Bank, National Association serving as the Syndication Agent. U.S. Bank National Association, Fifth Third Bank, Capital One, N.A., Regions Bank, Compass Bank and Bank of Montreal were documentation agents. The Bank of Nova Scotia and PNC Bank served as managing agents.
"The New Term Loan demonstrates the credit strengths of HTA's medical office building portfolio, its enterprise property management and leasing platform, and our strong and flexible balance sheet," stated Kellie S. Pruitt, Chief Financial Officer at HTA. "We are pleased to continue growing our relationships with these leading financial institutions."
Healthcare Trust of America, Inc.